Choosing the best systemic treatment sequence for control of tumour growth in gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): What is the recent evidence?-Reference-Cited by-同舟云学术

Choosing the best systemic treatment sequence for control of tumour growth in gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): What is the recent evidence?

Published:2023-09 Issue:5 Volume:37 Page:101836
ISSN:1521-690X
Container-title:Best Practice & Research Clinical Endocrinology & Metabolism
language:en
Short-container-title:Best Practice & Research Clinical Endocrinology & Metabolism

Author:

Passhak Maria,McNamara Mairéad G.,Hubner Richard A.,Ben-Aharon Irit,Valle Juan W.

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference79 articles.

1. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States;Dasari;JAMA Oncol,2017

2. Incidence and survival of neuroendocrine neoplasia in England 1995-2018: a retrospective, population-based study;White;Lancet Reg Health Eur,2022

3. One hundred years after ‘carcinoid’: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States;Yao;J Clin Oncol,2008

4. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters;Niederle;Endocr Relat Cancer,2010

5. Purpose of quality standards for infectious diseases. Infectious Diseases Society of America;Gross;Clin Infect Dis Publ Infect Dis Soc Am,1994

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum Concentrations of IGF-1R, ERK2, and EGFR and Their Clinical Significance in Patients with Neuroendocrine Tumors;Applied Sciences;2024-08-09

2. Update in the management of gastroenteropancreatic neuroendocrine tumors;Cancer;2024-07-16

3. Exploring Emerging Therapeutic Targets and Opportunities in Neuroendocrine Tumors: Updates on Receptor Tyrosine Kinases;Receptors;2024-04-05

4. Neuroendocrine Neoplasia: From Pathophysiology to Novel Therapeutic Approaches;Biomedicines;2024-04-04